Protherics PLC Notification of Major Interests in Shares London, UK; Brentwood, TN, US: 19 March 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces that, on 16 March 2007, a notification of interest in the ordinary share capital of the Company was received from AXA Investment Managers Limited on behalf of AXA S.A. in accordance with the Transparency Obligations Directive. Details of the interest notified are as follows: 1. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): CONFIRMATION OF CURRENT POSITION USING STANDARD FORM AS x REQUIRED BY EUTD REGULATIONS 2. Full name of person(s) subject to the AXA S.A., 25 Avenue Matignon, notification obligation: 75008 Paris and its group of companies. 3. Full name of shareholder(s) (if different from 2.): 4. Date of the transaction (and date on which 2 March 2007 the threshold is crossed or reached if different): 5. Date on which issuer notified: 16 March 2007 6. Threshold(s) that is/are crossed or reached: 7. Notified details: A: Voting rights attached to shares Class/type of Situation previous to Resulting situation after the triggering transaction shares the Triggering transaction if possible using Number of Number of Number of Number of voting rights % of voting rights the ISIN CODE Shares Voting shares Rights Direct Direct Indirect Direct Indirect GB0007029209 318,221 318,221 33,039,187 0.09% 9.74% B: Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration date Exercise/ Conversion Number of voting rights % of voting rights instrument Period/ Date that may be acquired if the instrument is exercised/ converted. Total (A+B) Number of voting rights % of voting rights 33,357,408 9.84% 8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable : Name of Company/Fund Number of Shares % of issued share capital AXA UK Investment Co ICVC 1,113,331 0.32831 UK Smaller Companies Fund Indirect Sun Life Pensions Management Ltd 11,250 0.00332 Direct Sun Life Unit Assurance Ltd 53,913 0.01590 FTSE All Share Tracker Direct Sun Life Pensions Management 253,058 0.07462 FTSE All Share Tracker Direct AXA Framlington 13,434,482 3.96170 UK Select Ops Indirect AXA Framlington 13,753,131 4.05567 Equity Income Indirect AXA Framlington 1,329,998 0.39220 Health Indirect AXA Framlington 900,000 0.26540 Managed Balanced Indirect AXA Framlington 592,599 0.17475 Biotech Indirect AXA Framlington 394,259 0.11626 BAE Systems Pensions Fund CIF Trustees Indirect AXA Framlington 176,049 0.05192 BAE Systems 2000 Pensions Fund Indirect Framlington onshore private clients 1,289,088 0.38014 Indirect Framlington onshor private clients 56,250 0.01659 Indirect Total Direct 318,221 0.09384 Total Indirect 33,039,187 9.74295 TOTAL 33,357,408 9.83679 Proxy Voting: 9. Name of the proxy holder: 10. Number of voting rights proxy holder will cease to hold: 11. Date on which proxy holder will cease to hold voting rights: 12. Additional information: | Ends | For further information please contact: Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518010 Financial Dynamics - press enquiries London: Ben Atwell, Anna Keeble +44 (0) 20 7831 3113 New York: John Capodanno, Jonathan Birt +1 212 850 5600 Or visit www.protherics.com This information is provided by RNS The company news service from the London Stock Exchange
Protherics PLC announce: Holding(s) in Company
| Source: Protherics PLC
Cheshire, UK -- (MARKET WIRE) -- March 19, 2007 --